Central Serous Chorioretinopathy (CSC) Not Yet Recruiting Phase 4 Trials for Aflibercept (DB08885)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment / Chorioretinal disorder / Chorioretinopathy / Chorioretinal disorder NOS

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02681783PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLiberceptTreatment